A detailed history of N Verses Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, N Verses Capital, LLC holds 5,600 shares of CORT stock, worth $313,152. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,600
Previous 3,900 43.59%
Holding current value
$313,152
Previous $127 Million 104.53%
% of portfolio
0.12%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$29.51 - $46.26 $50,167 - $78,642
1,700 Added 43.59%
5,600 $259 Million
Q2 2024

Jul 31, 2024

BUY
$22.21 - $34.48 $33,315 - $51,719
1,500 Added 62.5%
3,900 $127 Million
Q1 2024

Apr 25, 2024

BUY
$21.1 - $27.46 $50,640 - $65,904
2,400 New
2,400 $60.5 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.99B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.